Urologic surgeon Jonathan Coleman discusses approaches and techniques that have enabled surgeons to perform many kidney procedures in a less invasive manner.
Medical oncologist Robert Motzer discusses significant treatment advances and improved prognosis for patients with advanced renal cell carcinoma.
Patients with kidney cancer at Memorial Sloan Kettering receive care from a multidisciplinary Genitourinary Disease Management Team. We use advanced imaging techniques such as 3-D CT, 3-D MRI angiography, and CT urography to evaluate the renal pelvis and minimize diagnostic testing. Our physicians have expertise in standard open surgical approaches as well as minimally invasive techniques such as laparoscopic and robotic surgery, and we regularly perform partial nephrectomies and radical nephrectomies.
Minimally invasive procedures are an option for the majority of patients we see, and our research shows that more than 95 percent of individuals with tumors 4cm in size or smaller are eligible for such procedures. More than 80 percent of patients with tumors smaller than 7cm in size can be treated with minimally invasive techniques. We also offer image-guided ablation for nonsurgical candidates and are making advances in developing models for assessing risk for patients with metastatic renal cell carcinoma. Patients requiring systemic therapy may benefit from targeted immunotherapy agents.